Skip to primary navigation
Skip to main content
Join our community
Login
Enter your search
About
Editorial Board
About the Forum
Mission Statement
From the Editors
Expert Commentaries
Videos
News
Expert Meetings
Meeting Reports
News
Trials
About Trials
ANGPTL3 Inhibitors
ApoCIII Inhibitors
Icosapent Ethyl
SPPARM
View all Trials
Slides
Videos
Back To Basics
About hypertriglyceridaemia
Triglycerides, triglyceride-rich lipoproteins and remnants
Library
Guidelines
Key Publications
Resources
Forthcoming Meetings
Links
Register
Trials
You are here:
Home
> Archives for Trials
ANGPTL3 inhibitors
Read more about ANGPTL3 inhibitors »
Evinacumab (Evkeeza)
View the trials
Vupanorsen (Pfizer-led clinical development programme discontinued in January 2022)
View the trials
ApoCIII inhibitors
Read more about ApoCIII inhibitors »
Olezarsen (formerly AKCEA-APOCIII-LRx)
View the trials
Volanesorsen (Waylivra)
View the trials
Icosapent Ethyl
Read more about Icosapent Ethyl »
Icosapent ethyl (Vascepa)
View the trials
SPPARM
Read more about SPPARM »
Pemafibrate (Parmodia)
View the trials
Educational partners and supporters
